GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:007048220 | Esophagus | HGIN | response to oxygen levels | 76/2587 | 347/18723 | 2.36e-05 | 6.25e-04 | 76 |
GO:003629320 | Esophagus | HGIN | response to decreased oxygen levels | 70/2587 | 322/18723 | 6.23e-05 | 1.44e-03 | 70 |
GO:000166620 | Esophagus | HGIN | response to hypoxia | 67/2587 | 307/18723 | 7.82e-05 | 1.75e-03 | 67 |
GO:004343420 | Esophagus | HGIN | response to peptide hormone | 79/2587 | 414/18723 | 1.60e-03 | 1.79e-02 | 79 |
GO:190165318 | Esophagus | HGIN | cellular response to peptide | 68/2587 | 359/18723 | 3.88e-03 | 3.54e-02 | 68 |
GO:00064876 | Esophagus | HGIN | protein N-linked glycosylation | 17/2587 | 65/18723 | 6.04e-03 | 4.87e-02 | 17 |
GO:0070482111 | Esophagus | ESCC | response to oxygen levels | 218/8552 | 347/18723 | 6.91e-11 | 2.17e-09 | 218 |
GO:0036293111 | Esophagus | ESCC | response to decreased oxygen levels | 201/8552 | 322/18723 | 8.37e-10 | 2.04e-08 | 201 |
GO:0001666111 | Esophagus | ESCC | response to hypoxia | 192/8552 | 307/18723 | 1.59e-09 | 3.69e-08 | 192 |
GO:00086544 | Esophagus | ESCC | phospholipid biosynthetic process | 162/8552 | 253/18723 | 2.59e-09 | 5.73e-08 | 162 |
GO:000648714 | Esophagus | ESCC | protein N-linked glycosylation | 51/8552 | 65/18723 | 6.41e-08 | 1.13e-06 | 51 |
GO:00091002 | Esophagus | ESCC | glycoprotein metabolic process | 226/8552 | 387/18723 | 2.64e-07 | 3.94e-06 | 226 |
GO:190165319 | Esophagus | ESCC | cellular response to peptide | 208/8552 | 359/18723 | 1.68e-06 | 2.01e-05 | 208 |
GO:00181969 | Esophagus | ESCC | peptidyl-asparagine modification | 22/8552 | 24/18723 | 2.82e-06 | 3.21e-05 | 22 |
GO:0043434111 | Esophagus | ESCC | response to peptide hormone | 234/8552 | 414/18723 | 4.93e-06 | 5.21e-05 | 234 |
GO:00700854 | Esophagus | ESCC | glycosylation | 144/8552 | 240/18723 | 5.12e-06 | 5.38e-05 | 144 |
GO:00066446 | Esophagus | ESCC | phospholipid metabolic process | 218/8552 | 383/18723 | 5.37e-06 | 5.59e-05 | 218 |
GO:00182799 | Esophagus | ESCC | protein N-linked glycosylation via asparagine | 21/8552 | 23/18723 | 5.69e-06 | 5.90e-05 | 21 |
GO:00060668 | Esophagus | ESCC | alcohol metabolic process | 202/8552 | 353/18723 | 7.32e-06 | 7.26e-05 | 202 |
GO:00064865 | Esophagus | ESCC | protein glycosylation | 135/8552 | 226/18723 | 1.36e-05 | 1.24e-04 | 135 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
AGT | SNV | Missense_Mutation | | c.1298A>C | p.Glu433Ala | p.E433A | P01019 | protein_coding | tolerated(0.19) | benign(0.012) | TCGA-D1-A0ZO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
AGT | SNV | Missense_Mutation | rs201569036 | c.221N>T | p.Ala74Val | p.A74V | P01019 | protein_coding | deleterious(0.04) | benign(0.059) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
AGT | SNV | Missense_Mutation | novel | c.475N>A | p.Gln159Lys | p.Q159K | P01019 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
AGT | SNV | Missense_Mutation | novel | c.787N>C | p.Thr263Pro | p.T263P | P01019 | protein_coding | tolerated(0.1) | benign(0.006) | TCGA-D1-A1NU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
AGT | SNV | Missense_Mutation | rs61757175 | c.557C>T | p.Ala186Val | p.A186V | P01019 | protein_coding | tolerated(0.06) | benign(0.344) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
AGT | SNV | Missense_Mutation | | c.478N>A | p.Ala160Thr | p.A160T | P01019 | protein_coding | tolerated(0.44) | benign(0.037) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
AGT | SNV | Missense_Mutation | novel | c.225N>T | p.Lys75Asn | p.K75N | P01019 | protein_coding | deleterious(0.03) | benign(0.145) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
AGT | SNV | Missense_Mutation | novel | c.1343A>C | p.Lys448Thr | p.K448T | P01019 | protein_coding | tolerated(0.37) | benign(0) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
AGT | SNV | Missense_Mutation | | c.1110G>T | p.Lys370Asn | p.K370N | P01019 | protein_coding | tolerated(0.25) | benign(0.003) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
AGT | SNV | Missense_Mutation | novel | c.507G>T | p.Lys169Asn | p.K169N | P01019 | protein_coding | tolerated(0.18) | benign(0.049) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | QUINAPRIL | QUINAPRIL | 12693379,11849656 |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | chlorthalidone | CHLORTHALIDONE | |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | CYCLOSPORIN A | | 10642325 |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | ADENOVIRUS VECTOR | | 16014023 |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | Antiinflammatory agents, non-steroids | | 20538124 |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | CORTISOL | HYDROCORTISONE | 15576665 |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | Ace Inhibitors, Plain | | 14643574 |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | atenolol | ATENOLOL | 11593098,14700505 |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | irbesartan | IRBESARTAN | 11593098,15614026,14700505 |
183 | AGT | ENZYME, DRUGGABLE GENOME, PROTEASE INHIBITOR, G PROTEIN COUPLED RECEPTOR, HORMONE ACTIVITY, GROWTH FACTOR | | ANTI-ANGIOGENIC AGENTS | | 15578913 |